Safety, tolerability and immunologic activity of ruxolitinib added to suppressive art

Category Primary study
JournalTopics in Antiviral Medicine
Year 2019
This article has no abstract
Epistemonikos ID: 7ffd5f01f955c2c8ba9b57f471024c2fba0bd61c
First added on: Feb 12, 2025